Eli Lilly & Co.

NYS: LLY

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Feb 25, 2021, 8:48 a.m.

LLY
/zigman2/quotes/200106384/composite

$

204.20

Change

-0.32 -0.16%

Volume

Volume 572

Real time quotes

/zigman2/quotes/200106384/composite

Previous close

$ 204.52

$ 204.52

Change

+2.04 +1.01%

Day low

Day high

$201.63

$206.46

Open

52 week low

52 week high

$117.06

$218.00

Open

Annual Financials for Eli Lilly & Co.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 21.22B22.87B21.49B22.32B24.54B
Cost of Goods Sold (COGS) incl. D&A 5.65B6.07B4.68B4.72B5.48B
COGS excluding D&A 4.16B4.5B3.07B3.49B4.16B
Depreciation & Amortization Expense 1.5B1.57B1.61B1.23B1.32B
Depreciation 808.7M883.9M1.25B1.01B895.7M
Amortization of Intangibles 687.9M683.4M361.3M225.8M428.2M
Gross Income 15.57B16.8B16.81B17.6B19.06B
20162017201820192020 5-year trend
SG&A Expense 11.7B11.87B11.03B11.81B12.21B
Research & Development 5.24B5.28B5.05B5.6B6.09B
Other SG&A 6.45B6.59B5.98B6.21B6.12B
Other Operating Expense -----
Unusual Expense 590.6M2.88B2.15B1.02B565.5M
EBIT after Unusual Expense 3.28B(2.88B)(2.15B)4.77B6.28B
Non Operating Income/Expense 169.8M208M128.8M819.5M1.27B
Non-Operating Interest Income 108.7M167.3M159.3M80.4M33M
Equity in Affiliates (Pretax) -----
Interest Expense 185.2M225M242.5M400.6M359.6M
Gross Interest Expense 232.9M282.3M242.5M400.6M359.6M
Interest Capitalized 47.7M57.3M---
Pretax Income 3.37B2.2B3.68B5.27B7.23B
Income Tax 636.4M2.4B529.5M628M1.04B
Income Tax - Current Domestic (182M)3.15B174.3M265.8M520.3M
Income Tax - Current Foreign 378.9M38.5M106.8M299.8M650.4M
Income Tax - Deferred Domestic 522.8M(531.6M)(300,000)86.5M(117.9M)
Income Tax - Deferred Foreign (83.3M)(256.3M)248.7M(24.1M)(16.6M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 2.74B(204.1M)3.15B4.64B6.19B
Minority Interest Expense -----
Net Income 2.74B(204.1M)3.15B4.64B6.19B
Extraordinaries & Discontinued Operations --81.4M3.68B-
Extra Items & Gain/Loss Sale Of Assets --81.4M3.68B-
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 2.74B(204.1M)3.23B8.32B6.19B
Preferred Dividends -----
Net Income Available to Common 2.74B(204.1M)3.15B4.64B6.19B
EPS (Basic) 2.59(0.19)3.074.986.82
Basic Shares Outstanding 1.06B1.05B1.03B931.06M907.63M
EPS (Diluted) 2.58(0.19)3.054.966.79
Diluted Shares Outstanding 1.06B1.05B1.03B935.68M912.51M
EBITDA 5.37B6.5B7.39B7.02B8.17B
Link to MarketWatch's Slice.